Section R9-6-333. Haemophilus influenzae: Invasive Disease

A.      Case control measures:

1.        A diagnosing health care provider or an administrator of a health care institution, either personally or through a rep- resentative, shall isolate and institute droplet precautions for a Haemophilus influenzae meningitis or epiglottitis case or suspect case for 24 hours after the initiation of treatment.

2.        A local health agency shall:

a.        Conduct an epidemiologic investigation of each reported Haemophilus influenzae invasive disease case or suspect case; and

b.        For each Haemophilus influenzae invasive disease case, submit to the Department, as specified in Arti- cle 2, Table 4, the information required under R9-6- 206(D).

B.       Contact control measures: A local health agency shall evaluate the level of risk of transmission from each contact’s exposure to a Haemophilus influenzae invasive disease case and, if indi- cated, shall provide or arrange for each contact to receive immunization or treatment.

Historical Note

Renumbered from R9-6-726 and amended effective Octo- ber 19, 1993 (Supp. 93-4). Former Section R9-6-333 renumbered to R9-6-336; new Section R9-6-333 renum- bered from R9-6-330 effective April 4, 1997 (Supp. 97-2).

Former R9-6-333 renumbered to R9-6-341; new R9-6- 333 renumbered from R9-6-325 and amended by final rulemaking at 10 A.A.R. 3559, effective October 2, 2004 (Supp. 04-3). Former R9-6-333 renumbered to R9-6-335; new R9-6-333 renumbered from R9-6-331 and amended by final rulemaking at 14 A.A.R. 1502, effective April 1, 2008 (Supp. 08-2).